Beyond Air (XAIR) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $2.21, +5.24% vs the prior close of $2.10.
- Volume 33.20K shares, 0.1x its 50-day average (light).
- New SEC filings: 4 (Oct 14, 2026).
- No new insider buys or sales reported since the prior session.
XAIR jumps 5.2% to $2.21. Closed at $2.21, +5.24% vs the prior close of $2.10. Day range $2.07–$2.24, opened at $2.14.
XAIR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — XAIR jumps 5.2% to $2.21
- Closed at $2.21, +5.24% vs the prior close of $2.10. Day range $2.07–$2.24, opened at $2.14.
- Volume was 33.20K shares, 0.1x its 50-day average of 271.32K — lighter than usual.
- Price is -42.0% vs its 50-day average ($3.81) and -80.8% vs its 200-day average ($11.49).
- 52-week range $2.05–$55.00; today's close sits at 0% of that range, 96.0% below the 52-week high.
Oct 14, 2026 — XAIR slides 4.1% to $2.10, a 52-week low
- Closed at $2.10, -4.11% vs the prior close of $2.19. Day range $2.05–$2.25, opened at $2.18.
- Volume was 58.30K shares, 0.2x its 50-day average of 271.39K — lighter than usual.
- Price is -45.9% vs its 50-day average ($3.88) and -81.8% vs its 200-day average ($11.55).
- 52-week range $2.05–$55.00; today's close sits at 0% of that range, 96.2% below the 52-week high.
Oct 13, 2026 — XAIR slides 5.2% to $2.19, a 52-week low
- Closed at $2.19, -5.19% vs the prior close of $2.31. Day range $2.16–$2.37, opened at $2.35.
- Volume was 35.70K shares, 0.1x its 50-day average of 279.36K — lighter than usual.
- Price is -44.7% vs its 50-day average ($3.96) and -81.1% vs its 200-day average ($11.62).
- 52-week range $2.16–$55.00; today's close sits at 0% of that range, 96.0% below the 52-week high.
Oct 12, 2026 — XAIR rises 2.7% to $2.31
- Closed at $2.31, +2.67% vs the prior close of $2.25. Day range $2.24–$2.47, opened at $2.27.
- Volume was 30.20K shares, 0.1x its 50-day average of 279.36K — lighter than usual.
- Price is -42.9% vs its 50-day average ($4.04) and -80.2% vs its 200-day average ($11.69).
- 52-week range $2.20–$55.00; today's close sits at 0% of that range, 95.8% below the 52-week high.
Oct 9, 2026 — XAIR dips 2.6% to $2.25, a 52-week low, 4 down days in a row
- Closed at $2.25, -2.60% vs the prior close of $2.31. Day range $2.20–$2.34, opened at $2.30.
- Volume was 64.60K shares, 0.2x its 50-day average of 278.36K — lighter than usual.
- Price is -45.2% vs its 50-day average ($4.10) and -80.9% vs its 200-day average ($11.76).
- 52-week range $2.20–$55.60; today's close sits at 0% of that range, 96.0% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 — XAIR slides 9.1% to $2.31, a 52-week low, 3 down days in a row
- Closed at $2.31, -9.06% vs the prior close of $2.54. Day range $2.31–$2.76, opened at $2.76.
- Volume was 99.90K shares, 0.4x its 50-day average of 276.51K — lighter than usual.
- Price is -44.5% vs its 50-day average ($4.17) and -80.5% vs its 200-day average ($11.84).
- 52-week range $2.31–$55.60; today's close sits at 0% of that range, 95.8% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 8-K.
- This was a results day: the company filed an earnings release (8-K Item 2.02).
Oct 7, 2026 — XAIR dips 0.4% to $2.54, a 52-week low
- Closed at $2.54, -0.39% vs the prior close of $2.55. Day range $2.47–$2.60, opened at $2.49.
- Volume was 35.70K shares, 0.1x its 50-day average of 275.94K — lighter than usual.
- Price is -39.9% vs its 50-day average ($4.23) and -78.7% vs its 200-day average ($11.92).
- 52-week range $2.38–$55.60; today's close sits at 0% of that range, 95.4% below the 52-week high.
Oct 6, 2026 — XAIR slides 10.2% to $2.55, a 52-week low
- Closed at $2.55, -10.21% vs the prior close of $2.84. Day range $2.55–$2.82, opened at $2.76.
- Volume was 35.70K shares, 0.1x its 50-day average of 275.55K — lighter than usual.
- Price is -40.5% vs its 50-day average ($4.29) and -78.8% vs its 200-day average ($12.00).
- 52-week range $2.38–$55.60; today's close sits at 0% of that range, 95.4% below the 52-week high.
Oct 5, 2026 — XAIR rises 0.7% to $2.84
- Closed at $2.84, +0.71% vs the prior close of $2.82. Day range $2.81–$2.99, opened at $2.93.
- Volume was 42.90K shares, 0.2x its 50-day average of 274.87K — lighter than usual.
- Price is -34.6% vs its 50-day average ($4.34) and -76.5% vs its 200-day average ($12.08).
- 52-week range $2.38–$55.60; today's close sits at 1% of that range, 94.9% below the 52-week high.
Oct 2, 2026 — XAIR slides 3.8% to $2.82
- Closed at $2.82, -3.75% vs the prior close of $2.93. Day range $2.82–$2.99, opened at $2.93.
- Volume was 17.70K shares, 0.1x its 50-day average of 274.65K — lighter than usual.
- Price is -35.8% vs its 50-day average ($4.39) and -76.8% vs its 200-day average ($12.16).
- 52-week range $2.38–$55.60; today's close sits at 1% of that range, 94.9% below the 52-week high.
XAIR latest news & SEC filings
Every SEC filing by or about XAIR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lin Yi-Chien bought 2,607 shares at $2.21 (≈$5.76K) on Oct 13, 2026; now holds 148,000
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lin Yi-Chien bought 3,000 shares at $2.69 (≈$8.07K) on Sep 29, 2026; now holds 128,000
- Lin Yi-Chien bought 2,000 shares at $2.71 (≈$5.42K) on Sep 30, 2026; now holds 130,000
- Lin Yi-Chien bought 15,393 shares at $2.80 (≈$43.10K) on Oct 1, 2026; now holds 145,393
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 2, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 24, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 24, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 17, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.77M (prior year $1.76M) (+0.5% vs Jun 30, 2025)
- Net income: -$7.93M (prior year -$7.69M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$11.00 (prior year -$30.67) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 31, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Goodman Robert Scott bought 34,722 shares at $5.76 (≈$200.00K) on Jul 29, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 31, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Moorhead Daniel J bought 4,340 shares at $5.76 (≈$25.00K) on Jul 29, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade XAIR
- Last results release: Oct 8, 2026 (8-K Item 2.02). Previous ones: Aug 18, 2026, Jun 26, 2026, Feb 13, 2026. Based on that rhythm, the next report is likely around Jan 7, 2027 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.81% (largest 10.2%). That is a volatile stock.
- Liquidity: about 89.83K shares (≈$198.52K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.21 vs a range of $2.05–$55.00 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:20 on Jul 13, 2026, 1:20 on Jul 14, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 2 open-market buys, 0 sales; latest: Robert Scott Goodman bought 34,722 shares on Jul 29, 2026.
- Latest filings: 8-K Oct 8, 2026; 8-K Sep 24, 2026; 8-K Aug 18, 2026.
- Share count: 957.63K shares outstanding (Aug 12, 2026), -81.7% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
XAIR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 2.14 | 2.24 | 2.07 | 2.21 | 33.20K |
| Oct 14, 2026 | 2.18 | 2.25 | 2.05 | 2.10 | 58.30K |
| Oct 13, 2026 | 2.35 | 2.37 | 2.16 | 2.19 | 35.70K |
| Oct 12, 2026 | 2.27 | 2.47 | 2.24 | 2.31 | 30.20K |
| Oct 9, 2026 | 2.30 | 2.34 | 2.20 | 2.25 | 64.60K |
| Oct 8, 2026 | 2.76 | 2.76 | 2.31 | 2.31 | 99.90K |
| Oct 7, 2026 | 2.49 | 2.60 | 2.47 | 2.54 | 35.70K |
| Oct 6, 2026 | 2.76 | 2.82 | 2.55 | 2.55 | 35.70K |
| Oct 5, 2026 | 2.93 | 2.99 | 2.81 | 2.84 | 42.90K |
| Oct 2, 2026 | 2.93 | 2.99 | 2.82 | 2.82 | 17.70K |
| Oct 1, 2026 | 2.71 | 2.93 | 2.67 | 2.93 | 50.80K |
| Sep 30, 2026 | 2.74 | 2.80 | 2.66 | 2.76 | 38.90K |
| Sep 29, 2026 | 2.59 | 2.94 | 2.57 | 2.83 | 77.10K |
| Sep 28, 2026 | 2.85 | 2.85 | 2.38 | 2.59 | 156.50K |
| Sep 25, 2026 | 3.00 | 3.00 | 2.78 | 2.85 | 202.90K |
| Sep 24, 2026 | 3.01 | 3.21 | 2.85 | 3.17 | 702.60K |
| Sep 23, 2026 | 3.14 | 3.20 | 3.00 | 3.01 | 36.60K |
| Sep 22, 2026 | 3.15 | 3.20 | 3.05 | 3.20 | 15.60K |
| Sep 21, 2026 | 3.17 | 3.22 | 3.09 | 3.13 | 22.90K |
| Sep 18, 2026 | 3.07 | 3.26 | 3.07 | 3.09 | 38.80K |
About Beyond Air
Beyond Air (XAIR) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in GARDEN CITY, NY. State of incorporation: DE. Fiscal year ends March 31. SEC CIK 1641631.
XAIR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Robert Carey | Director | Nov 7, 2025 |
| William P Forbes | Director | Nov 6, 2025 |
| Robert Scott Goodman | Chief Executive Officer | Jul 31, 2026 |
| Yoori Lee | Director | Nov 24, 2025 |
| Steven A. Lisi | CEO and Chairman of the Board | Nov 6, 2025 |
| Erick Lucera | Director | Nov 6, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Michael A. Gaul | Chief Operating Officer | Nov 24, 2025 |
| Robert Scott Goodman | Chief Executive Officer | Jul 31, 2026 |
| Douglas Quinton Larson | Chief Financial Officer | Nov 6, 2025 |
| Steven A. Lisi | CEO and Chairman of the Board | Nov 6, 2025 |
| Daniel J Moorhead | Chief Financial Officer | Jul 31, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 29, 2026 | Robert Scott Goodman | Buy | 34,722 | $5.76 |
| Jul 29, 2026 | Daniel J Moorhead | Buy | 4,340 | $5.76 |
XAIR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Mar 31, 2026 | $7.68M | $-33.25M | -4.01 | $-18.14M |
| Mar 31, 2025 | $3.71M | $-46.62M | -13.77 | $-38.22M |
| Mar 31, 2024 | $1.16M | $-60.24M | -1.82 | $-56.01M |
| Mar 31, 2023 | — | $-55.82M | -1.86 | $-33.01M |
| Mar 31, 2022 | — | $-43.18M | — | $-23.13M |
Latest balance sheet: total assets $32.89M, total liabilities $30.05M, cash $5.51M (as of Jun 30, 2026).
XAIR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 8, 2026 | 8-K Item 2.02 (results) | $2.31 |
| Aug 18, 2026 | 8-K Item 2.02 (results) | $5.73 |
| Jun 26, 2026 | 8-K Item 2.02 (results) | $9.90 |
| Feb 13, 2026 | 8-K Item 2.02 (results) | $21.00 |
| Nov 14, 2025 | 8-K Item 2.02 (results) | $27.60 |
| Aug 18, 2025 | 8-K Item 2.02 (results) | $48.00 |
| Jun 18, 2025 | 8-K Item 2.02 (results) | $80.80 |
| Feb 14, 2025 | 8-K Item 2.02 (results) | $155.60 |
| Nov 18, 2024 | 8-K Item 2.02 (results) | $203.60 |
| Aug 9, 2024 | 8-K Item 2.02 (results) | — |
| Jun 27, 2024 | 8-K Item 2.02 (results) | — |
| Feb 16, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on XAIR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.